Herein, we present a novel TAAR1 ligand (JP-14) based on an aminoguanidine chemical scaffold and provide an in-depth evaluation of its pharmacological properties, with a particular focus on its potential application in the treatment of obesity and metabolic disturbances. Here, TAAR1 is linked to obesity disorder.